BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.21
-0.32 (-5.79%)
Oct 23, 2026, 10:12 AM EDT - Market open
BioAge Labs Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, BioAge Labs stock has a consensus rating of "Buy" and an average price target of $32.56. The average 1-year stock price forecast is 524.95% higher than the current stock price, while the lowest is $8.00 (+53.55%) and the highest is $73 (+1,301.15%).
Price Target: $32.56 (+524.95%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $21 | Buy | Maintains | $21 | +303.07% | Oct 15, 2026 |
| UBS | UBS | Hold Initiates $8 | Hold | Initiates | $8 | +53.55% | Oct 11, 2026 |
| Needham | Needham | Buy Maintains $35 | Buy | Maintains | $35 | +571.79% | Sep 14, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $25 | Buy | Reiterates | $25 | +379.85% | Sep 9, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $23 → $20 | Hold | Maintains | $23 → $20 | +283.88% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
7.53M
from 9.00M
Decreased by -16.32%
Revenue Next Year
14.88M
from 7.53M
Increased by 97.72%
EPS This Year
-2.43
from -2.24
EPS Next Year
-2.50
from -2.43
EPS and Forward PE are based on non-GAAP adjusted numbers.